Tubal ligation and survival of ovarian cancer patients

Journal of Obstetrics and Gynaecology Research

Volumn 38, Issue 1, 2012, Pages 40-47

  Zhang, Min ^a   Holman, C D'Arcy J ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Chinese women; Epithelial ovarian carcinoma; Prognostic factor; Survival; Tubal ligation

Indexed keywords

ARTICLE; ASCITES; BODY MASS; BREAST FEEDING; CANCER GRADING; CANCER SURVIVAL; CHINA; CYTOLOGY; FEMALE; FOLLOW UP; HAZARD RATIO; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; HYSTERECTOMY; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; MORTALITY; ORAL CONTRACEPTION; OVARY CANCER; PARITY; SURVIVAL TIME; UTERINE TUBE LIGATION;

ADULT; AGED; CARCINOMA; CASE-CONTROL STUDIES; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; STERILIZATION, TUBAL;

EID: 84863079615     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2011.01683.x     Document Type: Article

References (26)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249.
2. Hankinson S, Hunter D, Colditz G et al. Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study. JAMA 1993; 270: 2813-2818. (Pubitemid 23361643)
3. Kreiger N, Sloan M, Cotterchio M, Parsons P. Surgical procedures associated with risk of ovarian cancer. Int J Epidemiol 1997; 26: 710-715. (Pubitemid 27367845)
4. Miracle-McMahill HL, Calle EE, Kosinski AS et al. Tubal ligation and fatal ovarian cancer in a large prospective cohort study. Am J Epidemiol 1997; 145: 349-357. (Pubitemid 27082034)
5. Tavani A, Bosetti C, Dal Maso L, Giordano L, Franceschi S, La Vecchia C. Influence of selected hormonal and lifestyle factors on familial propensity to ovarian cancer. Gynecol Oncol 2004; 92: 922-926. (Pubitemid 38251397)
6. Westhoff C, Davis A. Tubal sterilization: Focus on the U.S. experience. Fertil Steril 2000; 73: 913-922. (Pubitemid 30227514)
7. Risch H, Marrett L, Howe G. Parity, contraception, infertility, and the risk of epithelial ovarian cancer. Am J Epidemiol 1994; 140: 585-597. (Pubitemid 24313016)
8. Beard CM, Hartmann LC, Atkinson EJ et al. The epidemiology of ovarian cancer: A population-based study in Olmsted County, Minnesota, 1935-1991. Ann Epidemiol 2000; 10: 14-23. (Pubitemid 30038214)
9. Gwinn ML, Lee NC, Rhodes PH, Layde PM, Rubin GL. Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancer. J Clin Epidemiol 1990; 43: 559-568. (Pubitemid 20178545)
10. Naik R, Nordin A, Cross PA, Hemming D, Lopes A, Monaghan JM. Risk factors in stage III epithelial ovarian cancer: Previous sterilisation is an adverse independent prognostic indicator. Eur J Gynaecol Oncol 2000; 21: 357-361.
11. Kjaerbye-Thygesen A, Frederiksen K, Høgdall EV, Høgdall CK, Blaakaer J, Kjaer SK. Do risk factors for epithelial ovarian cancer have an impact on prognosis? Focus on previous pelvic surgery and reproductive variables. Eur J Gynaecol Oncol 2006; 27: 467-472.
12. Nagle CM, Bain CJ, Green AC, Webb PM. The influence of reproductive and hormonal factors on ovarian cancer survival. Int J Gynecol Cancer 2008; 18: 407-413. (Pubitemid 351668299)
13. Yang L, Klint A, Lambe M et al. Predictors of ovarian cancer survival: A population-based prospective study in Sweden. Int J Cancer 2008; 123: 672-679. (Pubitemid 351898427)
14. Zhang M, Lee AH, Binns CW, Xie X. Green tea consumption enhances survival of epithelial ovarian cancer. Int J Cancer 2004; 112: 465-469. (Pubitemid 39390612)
15. Zhang M, Xie X, Lee AH, Binns CW, Holman CDJ. Body mass index in relation to ovarian cancer survival. Cancer Epidem Biomar 2005; 14: 1307-1310. (Pubitemid 40656486)
16. Zhang M, Lee AH, Binns CW. Reproductive and dietary risk factors for epithelial ovarian cancer in China. Gynecol Oncol 2004; 92: 320-326. (Pubitemid 38147409)
17. Cotran RS, Kumar V, Collins T. Robbins Pathologic Basis of Disease. Philadelphia, PA: W.B. Saunders Company, 1999.
18. Brun JL, Feyler A, Chene G, Saurel J, Brun G, Hocke C. Longterm results and prognostic factors in patients with epithelial ovarian cancer. Gynecol Oncol 2000; 78: 21-27. (Pubitemid 30439473)
19. Clark TG, Stewart ME, Altman DG, Gabra H, Smyth JF. A prognostic model for ovarian cancer. Br J Cancer 2001; 85: 944-952. (Pubitemid 33015994)
20. Chan JK, Tian C, Monk BJ et al. Prognostic factors for highrisk early-stage epithelial ovarian cancer: A Gynecologic Oncology Group study. Cancer 2008; 112: 2202-2210. (Pubitemid 351628630)
21. Lee Y, Miron A, Drapkin R et al. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol 2007; 211: 26-35. (Pubitemid 46092026)
22. Shih IM, Kurman RJ. Ovarian tumorigenesis: A proposed model based on morphological and molecular genetic analysis. Am J Pathol 2004; 164: 1511-1518. (Pubitemid 38529752)
23. O'Neill CJ, McBride HA, Connolly LE, Deavers MT, Malpica A, McCluggage WG. High-grade ovarian serous carcinoma exhibits significantly higher p16 expression than lowgrade serous carcinoma and serous borderline tumour. Histopathology 2007; 50: 773-779. (Pubitemid 46683935)
24. Cibula D, Widschwendter M, Májek O, Dusek L. Tubal ligation and the risk of ovarian cancer: Review and meta-analysis. Hum Reprod Update 2011; 17: 55-67.
25. Salvador S, Gilks B, Köbel M, Huntsman D, Rosen B, Miller D. The fallopian tube: Primary site of most pelvic highgrade serous carcinomas. Int J Gynecol Cancer 2009; 19: 58-64.
26. Salvador S, Rempel A, Soslow RA, Gilks B, Huntsman D, Miller D. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma. Gynecol Oncol 2008; 110: 408-417.